Out today in @TheLancetNeuro: We outline advances in complex regional pain syndrome epidemiology, pathophysiology, diagnosis & treatment. https://t.co/5P9ynucEvq

Amputation for complex regional pain syndrome: a systematic review

Complex Regional Pain Syndrome (CRPS) affects thousands of people every year, not only those diagnosed, but also their families and carers. NeuRA’s Centre for Pain IMPACT invites patients, carers, and loved ones to join us on Monday, 3 November, for an evening focused on lived

🟧 Living with complex regional pain syndrome (CRPS)? Patients, carers and family members in Sydney are warmly invited to join us on Monday 3 November for an evening focused on lived experience and practical approaches to CRPS management. Registration: https://t.co/KZUOGdEWHl

📣Recent perspective published in @PAINthejournal discusses the challenge of measuring and reporting adverse events in interventions for pain. 🔗 https://t.co/fxPyQHrcvE

To do no harm, we must first “know harms”. Our new perspective piece on the challenge of measuring and reporting adverse events in pain is now available in @PAINthejournal https://t.co/8X51NnkllP @mcferraro_ @aidancashin0 @EmmaFisher1 @IASP_MESISIG @IASPpain @EFIC_org

📣 What are the effects of ketamine and other NMDA antagonists for chronic pain? Read the recently published Cochrane review here 👉 https://t.co/rZwTZRKrw4 @mcferraro_

Ketamine use in chronic pain is unsupported by evidence https://t.co/R1kQgw6pNJ via @cochranecollab & @mcferraro_ et al

Is medical practice ahead of the evidence? Ketamine and other NMDA receptor antagonists for chronic pain - Ferraro, MC - 2025 | Cochrane Library

@BritishPainSoc @IASPpain @EFIC_org @BrunelResearch

Ketamine and other NMDA receptor antagonists for chronic pain https://t.co/cjjXZXuPL3

@Pain_NeuRa @NeilOConnell @AidanCashin @mawewege @AusPainSoc @ChronicPainAust @Painaustralia @ANZCA_FPM

Out today 🚨 Our Cochrane review of 67 RCTs finds no clear evidence of benefit for ketamine or other NMDA antagonists for chronic pain. IV ketamine associated with risk of psychotomimetic effects, nausea, and vomiting.

IASP members can catch the recording of this excellent session here:

Register now for the 5 Aug webinar from IASP’s Methodology, Evidence Synthesis, and Implementation SIG: Optimising Openness & Transparency in Pain Research Explore trust, rigor & tools like ENTRUST-PE & INSPECT-SR. https://t.co/Xlw0DiGZwi #IASP #PainResearch #ResearchIntegrity

One-Page Patient Fact Sheets for Low Back Pain in Primary Care

New paper: One-Page Patient Fact Sheets for Low Back Pain in Primary Care: A Randomized Clinical Trial What is the comparative effectiveness of 2 different fact sheets in preparing patients with low back pain for shared decision-making? https://t.co/kDrl9ME3JE #WiserHealthcare

Contrary to guidelines, patients with low back pain prefer facts, not advice.

One-Page Patient Fact Sheets for Low Back Pain in Primary Care Fact sheets do better than regular advice to support shared decision making! https://t.co/z8v1Xwba3c @PainIMPACTNeuRA @msk_health @Pain_NeuRa @AusPainSoc

One-Page Patient Fact Sheets for Low Back Pain in Primary Care